Exact Mass: 396.08788400000003
Exact Mass Matches: 396.08788400000003
Found 53 metabolites which its exact mass value is equals to given mass value 396.08788400000003,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sulfazecin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
methyl (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-6-(3-methoxypropyl)-4-(propylamino)-, 7,7-dioxide, (4S,6S)-
3,5,6-Trimethoxy-3,4-methylene-dioxyfurano[2,3:7,8]flavone
Me ester,di-Ac-3,8-Dihydroxy-1-methylanthraquinone-2-carboxylic acid
[4-(5,7-diacetyloxy-4-oxochromen-3-yl)phenyl] acetate
(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,9,10-tetrahydroxy-2,3-trans-3,4-dihydro-2H-benzofurano[2,3-h]chromene|gambircatechol
6,8-dimethoxy-7-(6?-methoxy-7?-coumarinyloxy)coumarin
N-Hydroxy-N-[1-[6-[1-(benzo[b]thiophene-2-yl)ethyl]benzo[b]thiophene-2-yl]ethyl]urea
3-(1-Oxo-3-hydroxy-2-butenyl)-4,5-dihydroxy-9,10-dihydro-9,10-dioxoanthracene-2-acetic acid methyl ester
1,4,5-Triacetoxy-2-methyl-anthrachinon|1,4,5-triacetoxy-2-methyl-anthraquinone|islandicin peracetate|islandicin triacetate|Islandicintriacetat|Islanelicintriacetat|Tri-Ac-1,4,5-Trihydroxy-2-methylanthraquinone|Tri-O-acetyl-islandicin
4-Demethyldehydropodophyllotoxin
Thiazopyr
Pre-emergence control herbicide, inhibitor of cell division. It is used on fruit trees, vines sugar cane, pineapples and citrus fruits CONFIDENCE standard compound; INTERNAL_ID 1070; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9520; ORIGINAL_PRECURSOR_SCAN_NO 9518 CONFIDENCE standard compound; INTERNAL_ID 1070; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9530; ORIGINAL_PRECURSOR_SCAN_NO 9527 CONFIDENCE standard compound; INTERNAL_ID 1070; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9534; ORIGINAL_PRECURSOR_SCAN_NO 9533 CONFIDENCE standard compound; INTERNAL_ID 1070; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9569; ORIGINAL_PRECURSOR_SCAN_NO 9568 CONFIDENCE standard compound; INTERNAL_ID 1070; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9593; ORIGINAL_PRECURSOR_SCAN_NO 9591 CONFIDENCE standard compound; INTERNAL_ID 1070; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9579; ORIGINAL_PRECURSOR_SCAN_NO 9577 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3052
Visor
(4,5-diacetyloxy-9,10-dioxoanthracen-2-yl)methyl acetate
fosbretabulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D000970 - Antineoplastic Agents
N,N-diethyl-4-[(1-methylpyridin-1-ium-4-yl)diazenyl]aniline,iodide
5,6-Dihydro-6-(3-methoxypropyl)-4-(propylamino)-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide
3-(4-Fluorophenoxy)-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide
3-(2-Furanylmethyl)-5,6-dimethyl-2-[(3-methylphenyl)methylthio]-4-thieno[2,3-d]pyrimidinone
Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium
methyl (1R,2R)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
Trans-combretastatin A-4 phosphate (*disodium salt*)
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide
C18H16N6OS2 (396.08269659999996)
1-[2-Furanyl(oxo)methyl]-6-(1-pyrrolidinylsulfonyl)-2-benzo[cd]indolone
N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide
(2Z)-2-[(3-Hydroxyphenyl)methylidene]-5,6-diphenylimidazo[2,1-b][1,3]thiazol-3-one
5-(3-Methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
[4,5-Dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid
Nogalaviketone
A methyl ester derived from (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid.
PIT
PIT (2,2'-Pyridylisatogen tosylate) is a selective and non-competitive antagonist of P2Y1 receptor with an IC50 value of 0.14 μM for human P2Y1 receptor. PIT antagonizes P2Y1 receptor signaling without affecting nucleotide binding. PIT is an irreversible antagonist of responses to ATP at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. PIT can be used for the research of chronic bronchitis and asthma[1][2][3].